Company profile OCX
After 38 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 53 days it will total up to 81.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 102 | 144 41.2% QoQ | 275 91.0% QoQ | 191 -30.5% QoQ |
| 2020 | 130 27.5% YoY -31.9% QoQ | 130 -9.7% YoY 0.0% QoQ | 198 -28.0% YoY 52.3% QoQ | 165 -13.6% YoY -16.7% QoQ |
| 2021 | 364 180.0% YoY 120.6% QoQ | 171 31.5% YoY -53.0% QoQ | 197 -0.5% YoY 15.2% QoQ | 90 -45.5% YoY -54.3% QoQ |
| 2022 | 278 -23.6% YoY 208.9% QoQ | 196 14.6% YoY -29.5% QoQ | 238 20.8% YoY 21.4% QoQ | 171 90.0% YoY -28.2% QoQ |
| 2023 | 93 -66.5% YoY -45.6% QoQ | 109 -44.4% YoY 17.2% QoQ | 113 -52.5% YoY 3.7% QoQ | 103 -39.8% YoY -8.8% QoQ |
| 2024 | 34 -63.4% YoY -67.0% QoQ | - | - | - |
The average 5 years interest of OncoCyte was 13.38 per week. The last year interest of OncoCyte compared to the last 5 years has changed by -41.93%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -47.18%.
After 38 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 53 days it will total up to 81.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 102 | 144 41.2% QoQ | 275 91.0% QoQ | 191 -30.5% QoQ |
| 2020 | 130 27.5% YoY -31.9% QoQ | 130 -9.7% YoY 0.0% QoQ | 198 -28.0% YoY 52.3% QoQ | 165 -13.6% YoY -16.7% QoQ |
| 2021 | 364 180.0% YoY 120.6% QoQ | 171 31.5% YoY -53.0% QoQ | 197 -0.5% YoY 15.2% QoQ | 90 -45.5% YoY -54.3% QoQ |
| 2022 | 278 -23.6% YoY 208.9% QoQ | 196 14.6% YoY -29.5% QoQ | 238 20.8% YoY 21.4% QoQ | 171 90.0% YoY -28.2% QoQ |
| 2023 | 93 -66.5% YoY -45.6% QoQ | 109 -44.4% YoY 17.2% QoQ | 113 -52.5% YoY 3.7% QoQ | 103 -39.8% YoY -8.8% QoQ |
| 2024 | 34 -63.4% YoY -67.0% QoQ | - | - | - |
The average 5 years interest of OncoCyte was 13.38 per week. The last year interest of OncoCyte compared to the last 5 years has changed by -41.93%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -47.18%.
After 38 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 53 days it will total up to 34.0. OCX stock expected interest is significantly lower compared to previous quarter (-60.9%) and same quarter last year (-64.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 170 | 200 17.6% QoQ | 74 -63.0% QoQ | 74 0.0% QoQ |
| 2020 | 193 13.5% YoY 160.8% QoQ | 256 28.0% YoY 32.6% QoQ | 281 279.7% YoY 9.8% QoQ | 282 281.1% YoY 0.4% QoQ |
| 2021 | 568 194.3% YoY 101.4% QoQ | 337 31.6% YoY -40.7% QoQ | 165 -41.3% YoY -51.0% QoQ | 120 -57.4% YoY -27.3% QoQ |
| 2022 | 109 -80.8% YoY -9.2% QoQ | 67 -80.1% YoY -38.5% QoQ | 75 -54.5% YoY 11.9% QoQ | 126 5.0% YoY 68.0% QoQ |
| 2023 | 95 -12.8% YoY -24.6% QoQ | 122 82.1% YoY 28.4% QoQ | 66 -12.0% YoY -45.9% QoQ | 87 -31.0% YoY 31.8% QoQ |
| 2024 | 14 -85.3% YoY -83.9% QoQ | - | - | - |
The average 5 years interest of OCX stock was 13.34 per week. The last year interest of OCX stock compared to the last 5 years has changed by -50.97%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -43.86%.
There is not enough data for OncoCyte DetermaRx to provide analysis
There is not enough data for OncoCyte DetermaRx to provide correlation calculation
There is not enough data for OncoCyte DetermaRx to provide analysis
There is not enough data for OncoCyte DetermaIO to provide analysis
There is not enough data for OncoCyte DetermaIO to provide correlation calculation
There is not enough data for OncoCyte DetermaIO to provide analysis
There is not enough data for OncoCyte biomarker testing to provide analysis
There is not enough data for OncoCyte biomarker testing to provide correlation calculation
There is not enough data for OncoCyte biomarker testing to provide analysis
There is not enough data for OncoCyte clinical trial support to provide analysis
There is not enough data for OncoCyte clinical trial support to provide correlation calculation
There is not enough data for OncoCyte clinical trial support to provide analysis
There is not enough data for OncoCyte collaboration agreement to provide analysis
There is not enough data for OncoCyte collaboration agreement to provide correlation calculation
There is not enough data for OncoCyte collaboration agreement to provide analysis
There is not enough data for OncoCyte headquarters to provide analysis
There is not enough data for OncoCyte headquarters to provide correlation calculation
There is not enough data for OncoCyte headquarters to provide analysis